Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-09-04Clinical Trial Update: Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease [Phase 1]
Phase 1 study evaluating single ascending doses of the AAB-001 vaccine in Japanese patients with Alzheimer's disease; the trial is completed…
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment [NA]
Clinical trial assessing early diagnosis of Alzheimer's disease through clinical, neuropsychological, and neuroimaging follow-up of a cohort…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Performance of AclarusDx® a Blood-Based Transcriptomic Test for AD, in French Patients Newly Referred to a Memory Center
A completed clinical trial evaluates how well AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, performs in French patie…
-
CLINICAL_TRIALS trial_result · 2014-08-19Clinical Trial Update: ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticE
The ADVANCE Study evaluating Alzheimer's disease in clinical practice has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Pharmacokinetic Interaction Between AZD3480 and Donepezil [Phase 1]
Phase 1 trial investigating the pharmacokinetic interaction between AZD3480 and donepezil in Alzheimer's disease has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: Escitalopram for the Treatment of Depression in Alzheimer's Disease [Phase 4]
A Phase 4 clinical trial evaluating escitalopram for depressive symptoms in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-08Clinical Trial Update: Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults [Phase 1]
Phase 1 clinical trial update reporting normative benchmarks for cognitive testing and Alzheimer's disease imaging biomarkers in young adult…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease [Phase 3]
Phase 3 study assessing 24-week efficacy, safety, and tolerability of rivastigmine transdermal patch in probable Alzheimer's disease; study …
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia [Phase 2]
This is a completed Phase 2 trial assessing the safety of E2020 (donepezil) 10 mg, followed by an open-label extension with E2020 SR 23 mg, …
-
CLINICAL_TRIALS trial_result · 2014-07-25Clinical Trial Update: Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal Elderly [Phase 1]
Phase 1 study evaluating a brain-computer interface-based system for cognitive enhancement in cognitively normal older adults. The trial sta…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Oxaloacetate Pharmacokinetics and Safety [NA]
A completed clinical trial assessing the pharmacokinetics and safety of oxaloacetate in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease [Phase 1]
A Phase 1 clinical trial by Bristol-Myers Squibb evaluating the safety, tolerability, and cerebrospinal fluid biomarker effects of BMS-24102…
-
CLINICAL_TRIALS trial_result · 2014-07-23Clinical Trial Update: Proof of Concept Study of Cognitive Improvement in Patients With Alzheimer's Disease [Phase 2]
Clinical trial update reports the completion of a Phase 2 proof-of-concept study evaluating cognitive improvement in patients with Alzheimer…
-
CLINICAL_TRIALS trial_result · 2014-07-16Clinical Trial Update: Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers [Phase 2]
Phase II study evaluating florbetaben PET imaging to detect or exclude cerebral beta-amyloid in patients with probable Alzheimer's disease; …
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Hormone and Information Processing Study [Phase 3]
Phase 3 clinical trial investigating a hormone- and information-processing–focused intervention for mild cognitive impairment and Alzheimer'…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological Markers [Phase 4]
This update reports the completion of a Phase 4 randomized trial comparing donepezil 10 mg daily to placebo in Alzheimer's disease, assessin…
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Safety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease [Phase 2]
Phase 2 safety study of TRx0237 in Alzheimer's disease patients already taking other Alzheimer's medications was terminated; results were po…
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease Patients [NA]
This clinical trial update notes the completion of a study evaluating a group therapy psychological intervention for caregivers of patients …
-
CLINICAL_TRIALS trial_result · 2014-07-09Clinical Trial Update: Experimental Study to Validate the "Therapeutic Game" CONEM-BETA [NA]
Clinical trial update indicating completion of an experimental study validating the 'Therapeutic Game' CONEM-BETA for Alzheimer's disease an…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Alzheimer and Sleep [Phase 1]
A Phase 1 clinical trial investigating sleep in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-03Clinical Trial Update: AZD3293 Thorough QT Study in Healthy Male Volunteers [Phase 1]
Phase 1 thorough QT study of lanabecestat (AZD3293) in healthy male volunteers to assess cardiac repolarization safety; the study sponsored …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Delta-THC in Dementia [Phase 2]
A Phase 2 trial evaluating delta-THC for behavioral disturbances and pain in dementia patients has completed. The study included Alzheimer's…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male Subjects [Phase 1]
A Phase I dose-escalation study evaluated the safety, tolerability, and pharmacokinetics of a transdermal donepezil patch in healthy male vo…
-
CLINICAL_TRIALS trial_result · 2014-06-27Clinical Trial Update: Citalopram for Agitation in Alzheimer's Disease [Phase 3]
The CitAD Phase 3 trial evaluating citalopram for agitation in Alzheimer's disease has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients [Phase 1]
Phase 1 trial evaluating florbetaben PET imaging to detect amyloid in individuals with mild cognitive impairment or Alzheimer's disease; res…